# US 2015/0147359 A1 · Suspension compositions of physiologically active phenolic compounds & methods of making and using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147359 A1
- Document ID: US20150147359A1
- Status: Published application
- Kind: A1
- Application number: 14/090,864
- Filed: 2013-11-26
- Published: 2015-05-28
- Earliest claimed: 2013-11-26
- Assignees: Humanetics Corporation
- Applicants: Humanetics Corporation
- Inventors: David C. Egberg; Michael D. Kaytor; John C. Dykstra
- Web page: https://patentgrep.com/patent/US20150147359A1

## CPC

- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A23K 20/111: Aromatic compounds
- A23K 20/158: Fatty acids; Fats; Products containing oils or fats
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/115: Fatty acids or derivatives thereof; Fats or oils
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/10: Dispersions; Emulsions
- A61K 9/145: {with organic compounds}
- A61K 9/148: {with compounds of unknown constitution, e.g. material from plants or animals (with oils, fats, waxes, shellac A61K9/145)}
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23K: FODDER
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)

## Abstract

The present invention is directed to compositions comprising physiologically active phenolic compounds and methods for making and using the same. In particular embodiments, the compositions described herein include suspension formulations including a physiologically active phenolic compound provided as a nanoparticulate material and dispersed within an edible lipid.

## Claims

### Claim 1

A composition suitable for consumption by a subject, the composition comprising:
an edible lipid; and
an active material suspended within the edible lipid forming a nanoparticulate suspension, wherein the active material comprises a physiologically active phenolic compound and exhibits a particle size distribution characterized by a D (0.50) of 0.5 μm or less.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the active material exhibits a particle size distribution characterized by a D (0.50) selected from a D (0.50) of 0.4 μm or less, a D (0.50) of 0.35 μm or less, a D (0.50) of 0.30 μm or less, a D (0.50) of 0.25 μm or less, and a D (0.50) of 0.20 μm or less.

### Claim 3 (depends on 2)

The composition according to claim 2, wherein the active material exhibits a particle size distribution characterized by a D(0.50) of 0.3 μm or less.

### Claim 4 (depends on 2)

The composition according to claim 2, wherein the active material exhibits a particle size distribution characterized by a D (0.90) of 2.0 μm or less.

### Claim 5 (depends on 4)

The composition according to claim 4, wherein the active material exhibits a particle size distribution characterized by a D (0.90) selected from a D (0.90) of 1.5 μm or less, a D (0.90) of 1.0 μm or less, and a D (0.90) of 0.5 μm or less.

### Claim 6 (depends on 2)

The composition according to claim 2, wherein the physiologically active phenolic compound is selected from the group consisting of isoflavones, curcuminoids, flavonols, stilbenoids, and combinations thereof.

### Claim 7 (depends on 6)

The composition according to claim 6, wherein the physiologically active phenolic compound is selected from the group consisting of curcumin, desmethoxycurcumin, bis-desmethoxycurcumin, genistein, daidzein, catechin, epicatechin, EGCG, resveratrol, and combinations of two of more of such compounds.

### Claim 8 (depends on 6)

The composition according to claim 6, wherein the physiologically active phenolic compound is genistein.

### Claim 9 (depends on 6)

The composition according to claim 6, further comprising a dispersant selected from the group consisting of lecithin, polysorbate 80, steroyl-2-lactate, polyoxyethylene esters, sucrose esters of fatty acids, polyglycerol esters, fatty acid esters of propylene glycol, and glycerol fatty acid esters.

### Claim 10

(canceled)

### Claim 11 (depends on 6)

The composition according to claim 6, wherein the edible lipid is an edible glyceride having a chain length ranging from one carbon acetate to 22 carbons, and wherein the edible glyceride is selected from the group consisting of mono-glycerides, di-glycerides, and triglycerides.

### Claim 12

(canceled)

### Claim 13 (depends on 6)

The composition according to claim 6, wherein the edible lipid is an edible plant oil or animal oil selected from the group consisting of olive, corn, soy, marine, coconut, palm, palm kernel, cotton seed, peanut, safflower, sesame, sunflower, almond, cashew, macadamia, pecan, pine nut, walnut, lemon, orange, flax seed, borage oils, fish oils, and dairy derived fats.

### Claim 14 (depends on 8)

The composition according to claim 8, wherein the edible lipid comprises olive oil.

### Claim at position 15

15-28. (canceled)

### Claim 29

A method for preparing an edible suspension of a physiologically active phenolic compound, the method comprising:
providing an edible lipid;
providing an active material comprising a physiologically active phenolic compound; and
milling the active material in the presence of the edible lipid to form a nanoparticulate suspension of the active material suspended within the edible lipid, wherein the active material in the nanoparticulate suspension exhibits a particle size distribution characterized by a D(0.50) of 0.5 μm or less, and wherein milling the active material in the presence of the edible lipid comprises nanomilling the active material in a milling media that comprises the edible lipid.

### Claim 30

(canceled)

### Claim 31 (depends on 29)

The method according to claim 29, wherein, prior to milling the active material in the presence of the edible lipid, the active material is suspended within the lipid and milling the active material in the presence of the edible lipid comprises introducing the combined active material and edible lipid into a nanomill and processing the combined active material and lipid within the nanomill until the active material exhibits a desired particle size distribution.

### Claim 32 (depends on 29)

The method according to claim 29, wherein milling the active material in the presence of the edible lipid comprises milling the active material until the active material exhibits a particle size distribution characterized by a D (0.50) selected from a D (0.50) of 0.4 μm or less, a D (0.50) of 0.35 μm or less, a D (0.50) of 0.30 μm or less, a D (0.50) of 0.25 μm or less, and a D (0.50) of 0.20 μm or less.

### Claim 33 (depends on 32)

The method according to claim 32, wherein milling the active material in the presence of the edible lipid comprises milling the active material until the active material exhibits a particle size distribution characterized by a D(0.50) of 0.3 μm or less.

### Claim 34 (depends on 32)

The method according to claim 32, wherein milling the active material in the presence of the edible lipid comprises milling the active material until the active material exhibits a particle size distribution characterized by a D (0.90) of 2.0 μm or less.

### Claim 35 (depends on 34)

The method according to claim 34, wherein milling the active material in the presence of the edible lipid comprises milling the active material until the active material exhibits a particle size distribution characterized by a D (0.90) selected from a D (0.90) of 1.5 μm or less, a D (0.90) of 1.0 μm or less, and a D (0.90) of 0.5 μm or less.

### Claim 36 (depends on 32)

The method according to claim 32, wherein the physiologically active phenolic compound is selected from the group consisting of isoflavones, curcuminoids, flavonols, stilbenoids, and combinations thereof.

### Claim 37 (depends on 36)

The method according to claim 36, wherein the physiologically active phenolic compound is selected from the group consisting of curcumin, desmethoxycurcumin, bis-desmethoxycurcumin, genistein, daidzein, catechin, epicatechin, EGCG, resveratrol, and combinations of two of more of such compounds.

### Claim 38 (depends on 37)

The method according to claim 37, wherein the physiologically active phenolic compound is genistein.

### Claim 39 (depends on 36)

The method according to claim 36, further comprising providing a dispersant, wherein the dispersant is blended with the edible lipid and the active material, and wherein the dispersant is selected from the group consisting of lecithin, polysorbate 80, steroyl-2-lactate, polyoxyethylene esters, sucrose esters of fatty acids, polyglycerol esters, fatty acid esters of propyleneglycol, and glycerol fatty acid esters.

### Claim 40

(canceled)

### Claim 41 (depends on 36)

The method according to claim 36, wherein the edible lipid is an edible glyceride having a chain length ranging from one carbon acetate to 22 carbons, and wherein the edible glyceride is selected from the group consisting of mono-glycerides, di-glycerides, and triglycerides.

### Claim 42

(canceled)

### Claim 43 (depends on 36)

The method according to claim 36, wherein the edible lipid is an edible plant oil or animal oil selected from the group consisting of olive, corn, soy, marine, coconut, palm, palm kernel, cotton seed, peanut, safflower, sesame, sunflower, almond, cashew, macadamia, pecan, pine nut, walnut, lemon, orange, flax seed, borage oils, fish oils, and dairy derived fats.

### Claim 44 (depends on 1)

The composition according to claim 1, wherein the concentration of the active material in the nanoparticulate suspension is 200 mg/ml or higher.

### Claim 45 (depends on 44)

The composition according to claim 44, wherein the concentration of the active material in the nanoparticulate suspension is selected from a concentration of 250 mg/ml or higher, a concentration of 300 mg/ml or higher, a concentration of 350 mg/ml or higher, a concentration of 400 mg/ml or higher, a concentration of 450 mg/ml or higher, and a concentration of 500 mg/ml or higher.

### Claim 46 (depends on 29)

The method according to claim 29, wherein the concentration of the active material in the nanoparticulate suspension is 200 mg/ml or higher.

### Claim 47 (depends on 46)

The method according to claim 46, wherein the concentration of the active material in the nanoparticulate suspension is selected from a concentration of 250 mg/ml or higher, a concentration of 300 mg/ml or higher, a concentration of 350 mg/ml or higher, a concentration of 400 mg/ml or higher, a concentration of 450 mg/ml or higher, and a concentration of 500 mg/ml or higher.

### Claim 48 (depends on 36)

The method according to claim 36, wherein the concentration of the active material in the nanoparticulate suspension is 200 mg/ml or higher.

### Claim 49 (depends on 48)

The method according to claim 48, wherein the concentration of the active material in the nanoparticulate suspension is selected from a concentration of 250 mg/ml or higher, a concentration of 300 mg/ml or higher, a concentration of 350 mg/ml or higher, a concentration of 400 mg/ml or higher, a concentration of 450 mg/ml or higher, and a concentration of 500 mg/ml or higher.
